Prudential Financial’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $158K | Buy |
+13,439
| New | +$158K | ﹤0.01% | 2246 |
|
|
2024
Q3 | – | Sell |
-23,739
| Closed | -$531K | – | 2772 |
|
|
2024
Q2 | $531K | Buy |
23,739
+298
| +1% | +$6.67K | ﹤0.01% | 2161 |
|
|
2024
Q1 | $645K | Buy |
23,441
+15,632
| +200% | +$430K | ﹤0.01% | 2058 |
|
|
2023
Q4 | $238K | Buy |
7,809
+125
| +2% | +$3.81K | ﹤0.01% | 2389 |
|
|
2023
Q3 | $243K | Buy |
7,684
+499
| +7% | +$15.8K | ﹤0.01% | 2332 |
|
|
2023
Q2 | $293K | Buy |
7,185
+568
| +9% | +$23.2K | ﹤0.01% | 2304 |
|
|
2023
Q1 | $357K | Sell |
6,617
-115
| -2% | -$6.21K | ﹤0.01% | 2218 |
|
|
2022
Q4 | $235K | Buy |
6,732
+204
| +3% | +$7.12K | ﹤0.01% | 2353 |
|
|
2022
Q3 | $361K | Buy |
6,528
+141
| +2% | +$7.8K | ﹤0.01% | 2217 |
|
|
2022
Q2 | $335K | Sell |
6,387
-16,568
| -72% | -$869K | ﹤0.01% | 2299 |
|
|
2022
Q1 | $1.67M | Sell |
22,955
-68,927
| -75% | -$5.01M | ﹤0.01% | 1614 |
|
|
2021
Q4 | $11M | Buy |
91,882
+25,060
| +38% | +$3.01M | 0.01% | 700 |
|
|
2021
Q3 | $9.11M | Sell |
66,822
-374
| -0.6% | -$51K | 0.01% | 762 |
|
|
2021
Q2 | $10.9M | Buy |
67,196
+9,792
| +17% | +$1.59M | 0.01% | 735 |
|
|
2021
Q1 | $4.61M | Buy |
57,404
+52,470
| +1,063% | +$4.21M | 0.01% | 1064 |
|
|
2020
Q4 | $269K | Buy |
+4,934
| New | +$269K | ﹤0.01% | 2277 |
|